journal article May 01, 2013

Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: Findings from a randomised trial

European Journal of Cancer Vol. 49 No. 8 pp. 1923-1931 · Elsevier BV
View at Publisher Save 10.1016/j.ejca.2013.01.027
Topics

No keywords indexed for this article. Browse by subject →

References
30
[1]
Baujat "Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients" Int J Radiat Oncol Biol Phys (2006) 10.1016/j.ijrobp.2005.06.037
[2]
"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies" Lancet (2004) 10.1016/s0140-6736(03)15268-3
[3]
Mor "The Karnofsky performance status scale. An examination of its reliability and validity in a research setting" Cancer (1984) 10.1002/1097-0142(19840501)53:9<2002::aid-cncr2820530933>3.0.co;2-w
[4]
Munstedt "Influence of body mass index on prognosis in gynecological malignancies" Cancer Causes Control (2008) 10.1007/s10552-008-9152-7
[5]
Pai "Impact of pretreatment body mass index on patients with head-and-neck cancer treated with radiation" Int J Radiat Oncol Biol Phys (2012) 10.1016/j.ijrobp.2011.11.071
[6]
Park "Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study" J Clin Oncol (2006) 10.1200/jco.2006.07.0243
[7]
Parker "Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma" Urology (2006) 10.1016/j.urology.2006.05.024
[8]
Simkens "Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy" Eur J Cancer (2011) 10.1016/j.ejca.2011.06.038
[9]
Mauland "High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer" Br J Cancer (2011) 10.1038/bjc.2011.46
[10]
Dawood "Prognostic value of body mass index in locally advanced breast cancer" Clin Cancer Res (2008) 10.1158/1078-0432.ccr-07-1479
[11]
Efstathiou "Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer" Cancer (2007) 10.1002/cncr.22564
[12]
Zhang "Body mass index in relation to ovarian cancer survival" Cancer Epidemiol Biomarkers Prev (2005) 10.1158/1055-9965.epi-04-0519
[13]
Hu "Impact of pretherapy body mass index on prognosis of nasopharyngeal carcinoma" Ai Zheng (2009)
[14]
Huang "A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma" Oral Oncol (2012) 10.1016/j.oraloncology.2012.04.006
[15]
Tai-Xiang "A probe of design methods of block shielding facio cervical portals at isocentre for radiotherapy of nasopharyngeal carcinoma" Ai Zheng (2000)
[16]
Hong "A comparison of the Chinese 1992 and fifth-edition International Union Against Cancer staging systems for staging nasopharyngeal carcinoma" Cancer (2000) 10.1002/1097-0142(20000715)89:2<242::aid-cncr6>3.0.co;2-z
[17]
Dhanapal "Cancer cachexia" J Oral Maxillofac Pathol (2011) 10.4103/0973-029x.86670
[18]
Van Cutsem "The causes and consequences of cancer-associated malnutrition" Eur J Oncol Nurs (2005) 10.1016/j.ejon.2005.09.007
[19]
Capuano "Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment" Support Care Cancer (2010) 10.1007/s00520-009-0681-8
[20]
Trotti "Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review" Radiother Oncol (2003) 10.1016/s0167-8140(02)00404-8
[21]
Nourissat "Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer" Support Care Cancer (2012) 10.1007/s00520-011-1132-x
[22]
Lee "Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group" J Clin Oncol (2005) 10.1200/jco.2004.00.7542
[23]
Ewertz "Effect of obesity on prognosis after early-stage breast cancer" J Clin Oncol (2011) 10.1200/jco.2010.29.7614
[24]
Gong "Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men" Cancer (2007) 10.1002/cncr.22534
[25]
Lee "Current management of nasopharyngeal cancer" Semin Radiat Oncol (2012) 10.1016/j.semradonc.2012.03.008
[26]
Calle "Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults" N Engl J Med (2003) 10.1056/nejmoa021423
[27]
Demark-Wahnefried "The role of obesity in cancer survival and recurrence" Cancer Epidemiol Biomarkers Prev (2012) 10.1158/1055-9965.epi-12-0485
[28]
Chua "Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone" Cancer (2004) 10.1002/cncr.20366
[29]
Li "Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma" J Transl Med (2008) 10.1186/1479-5876-6-1
[30]
Chua "Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy" Int J Radiat Oncol Biol Phys (2004) 10.1016/j.ijrobp.2003.10.038
Metrics
62
Citations
30
References
Details
Published
May 01, 2013
Vol/Issue
49(8)
Pages
1923-1931
License
View
Authors
Funding
National Natural Science Foundation of China Award: 30600755
Fundamental Research Funds for the Central Universities
Cite This Article
Pei-Yu Huang, Cheng-Tao Wang, Ka-Jia Cao, et al. (2013). Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: Findings from a randomised trial. European Journal of Cancer, 49(8), 1923-1931. https://doi.org/10.1016/j.ejca.2013.01.027